New Antivirals Help Thwart Global Threat to Public Health

Research and Markets have announced the addition of Antivirals: Technologies, Trends, and Market Opportunities report to their offering.

(PRWEB) November 13, 2003 --Over the last decade, a global threat to public health has continued to rise, and in fact, will worsen in future decades unless effective antiviral therapies are introduced. For example, approximately two billion people are infected with the hepatitis B virus globally. Of those infected, between 300-350 million are chronic carriers of the virus but remain asymptomatic. Even in the U.S., where the hepatitis B vaccine has been available since the early 1980s, an estimated one million people are carriers of the hepatitis B virus, and the number of chronic carriers is expected to grow to 1.7 million by 2010.

This Market Analysis Report, Antivirals: Technologies, Trends, and Market Opportunities, will bring you up to date by assessing the latest trends, technologies, and strategies in the antivirals industry. New targets for antiviral agents are examined, and key pharmaceutical company alliances identified.New drugs are urgently needed to combat viral diseases and resistant viruses. More importantly, scientific methods to continually discover replacement drugs are necessary; each time a new antiviral is developed using currently popular approaches, there will undoubtedly be resistance. New technologies have the potential to change this by providing information that can be developed into new antiviral strategies. The future promises great opportunities for innovative companies that remain at the forefront of drug discovery technology. D&MD's Antivirals Report will provide you with the tools to stay ahead of the competition.

Unique Benefits

1. Analysis of current industry trends and strategies, providing insight into potential sales and profits for your business

2. Assessment of the latest technologies impacting existing antivirals, identifying new opportunities to overcome the issue of resistance

3. Examination of the new targets for novel antiviral agents revealed by genomics, recognizing their affect on the future of the market

4. Discussion of market and technology trends within the antiviral industry, presenting the information needed for successful strategic planning and
collaborative opportunities

5. Evaluation of key pharmaceutical company alliances, identifying successful partnerships to benchmark future deals

For a complete index of this report click on http://www.researchandmarkets.com/reports/39135

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com
###